Source: Annual Congress 2010 - Proteases and the matrix
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mauad, R. Annoni, T. Lancas, S. Fernezlian, L. F. Silva, B. Andreina, S. Battaglia, M. Dolhnikoff, P. Hiemstra, P. Sterk, K. Rabe (Sao Paulo, Brazil; Palermo, Italy; Amsterdam, Netherlands). Collagen I, III and IV content in airways and lung parenchyma of COPD patients. Eur Respir J 2010; 36: Suppl. 54, 4371

Member's Comments

No comment yet.

Related content which might interest you: Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 The influence of roflumilast on the IV-type collagen level in patients with III stage COPD Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006 Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Increased urotensin II in BALF and lung tissue in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Transplant of alveolar type II cells restore pulmonary surfactant in lung fibrosis Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Effects of pulmonary rehabilitation on peripheral muscle fibre characteristics in COPD patients with gold stages II to IV Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009 A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Respiratory function in stage II pulmonary sarcoidosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 385s Year: 2001 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012 Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 The dynamics of IV-type collagen contents in BALF of patients with COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 The role of cell lines in modelling the type II pneumocyte in interstitial lung disease Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease Year: 2020 TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005